LBA 2 Phase Ⅲ,randomized,open-label,first-line study of gefitonib(G) vs carboplatin/paclitaxel(C/P)in clinically selected patients) with advanced non-small-cell lung cancer(NSCLC)

查看全文 作　　者：Tony M;Yi-Long Wu;Sumitra;S; 出　　处：《Annals of Oncology》索引2008年第19卷第8期,共0页